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In this summary of therapy for severe asthma 
there is no mention of etiologic factors. The author 
presumes that if infection is the primary factor in 
the progression to severe asthma that this will 
be recognized and appropriately treated. A chest 
x-ray must be an initial laboratory study for the 
recognition of pneumonia or complicating pneu-
mothorax. However, unlike respiratory failure due 
to emphysema, here the specific therapy of the 
altered pulmonary physiology is of paramount 
importance. Attention to the inciting factors is of 
minimal therapeutic benefit once infection can be 
ruled out. After the patient can breathe comfort-
ably again the role of allergy can be investigated. 
Premature investigation of emotional factors can 
be a lethal therapeutic error in the ill asthmatic. 
The treatment of asthma at the University of 
Virginia Hospital can be divided into three rather 
specific periods (Table 1). 
Mystery Period. Until 1962 arterial blood 
gas and pH measurement were not routinely avail-
able as a clinical tool in our laboratories. Most pa-
tients with severe asthma did well with our rou-
tine management. Other patients who looked the 
same might die suddenly with no major change in 
their clinical course. The mystery revolved around 
our inability to judge precisely who had life 
threatening asthma and who did not. 
Measurement and Aggression 1962-1968. 
(Table 2). As soon as arterial puncture became a 
routine procedure the mystery cleared somewhat. 
Many patients with severe asthma were found to 
our surprise to have severe hypoxemia and hy-
percarbia. It is presumed that the prior mystery 
deaths were most likely due to respiratory failure 
with CO~ narcosis or hypoxemia-induced fatal ar-
* Presented by Dr. Hunt at the Symposium on Respira-
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rhythmias. These patients were recognized usually 
late in their disease. Immediate tracheostomy was 
done; many were hyperventilated with a volume 
controlled ventilator into frightening states of 
alkalosis, and the hospitalization was prolonged 
for two to three weeks. The patients did not die 
from asthma, however, and survived their respira-
tory care (3). 
Measurement and Intensive Care. Employ-
ing the lessons learned from our middle period, 
since 1968 our management of severe asthma has 
changed (Table 3) . In the period 1965-1967, 
10 patients with severe asthma were ventilated fol-
lowing tracheostomy and all survived. From 1968 
to 1971 there were 299 admissions of asthmatics 
to the University of Virginia Hospital. Of these 
patients, 50 were judged to be in status asthma, 
and 36 had a P co, greater than 45 mm Hg. Despite 
the serious nature of their disease, only 8 pa-
tients were intubated, 6 were briefly ventilated, 
and only 1 patient needed a tracheostomy. No 
deaths occurred ( 4). 
Common Errors in Management. (Table 4). 
A review of patients previously reported with tra-
cheostomy and our current series since 1968 re-
vealed the same errors in management with the 
difference being one of degree. 
Steroids. In the prior series, two patients re-
ceived no steroids at all prior to tracheostomy. In 
our current patient group, several who were intu-
bated received steroids late in their clinical course 
and in small amounts. 
Sedation. The use of sedation continues to 
be an identifiable factor probably responsible for 
the deterioration and intubation in at least half of 
the patients intubated since I 968. Valium® and 
other tranquilizers are replacing the barbiturates as 
major offenders. Sedatives have no place in the 
management of severe asthma. 
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TABLE I. 
MANAGEMENT OF SEVERE ASTHMA 
University of Virginia Hospital 
Mystery Period- Until 1962 
Measurement and Aggression 1962- 1968 
Measurement and Intensive Care 1968- Present 
Oxygen. The indiscriminate use of high flow 
oxygen is not as devastating to the asthmatic in 
acute respiratory failure as to the patient with 
chronic bronchitis and emphysema. An attempt 
should be made to keep the arterial oxygen in the 
physiologic range (70-110 mm Hg) which gen-
erally means the use of no more than 28-35% 
oxygen. 
Nursing Position. Classically, the patient with 
asthma is immediately put flat in bed, and, to 
make sure he stays there, intravenous fluids are 
begun apparently to facilitate rapid drug admin-
istration. Like the patient with emphysema, the 
asthmatic is much more comfortable breathing 
in a chair. IV fluids should be replaced with oral 
medication usually within 24-48 hours except in 
unusual circumstances. This can be of immense 
psychological benefit as well as prevent painful 
phlebitis. 
Tracheostomy. From our current experience 
and that of others ( 2), tracheostomy should rarely 
be necessary in the management of asthma. 
The morbidity associated with the procedure it-
self and the prolongation of hospital care, coupled 
with the short clinical course of aggressively treated 
asthma, all make nasotracheal tube intubation 
the procedure of choice when respiratory failure 
supervenes. 
Patients at Risk. Who are the patients who are 
in the most danger of progression to respiratory fail-
ure? The same group (Table 5) appears in every 
series. 
TABLE 2. 
MEASUREMENT AND AGGRESSION 1962- 1968 
Arterial Gas Measurements Begun in 1962 
Usually Obtained Late in Course 
Serious Nature of Disease Recognized 
Usually Immediate Tracheostomy 
Frequently Hyperventilated 
Two to Three Week Hospitalization 
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TABLE 3. 
MEASUREMENT AND INTENSIVE CARE 1968- PRESENT 
Arterial Gas Measurement Early in Suspicious Cases 
Review of Prior Medication Imperative 
Uncomplicated Asthma- Low P 0 ,- Lo1v Pco, 
Severe Asthma-Normal Pco, a Grave Prognostic Sign 
How to Evaluate Severity of Asthma. 
Prior Medications. A patient who is in marked 
respiratory distress with asthma, and who has taken 
only a few tablets in the prior 24 hours, is in a dif-
ferent prognostic category than the patient with 
the same degree of airway obstruction who has 
tried Tedral®, aminophylline suppositories, and 20 
mg of prednisone two hours before. An assess-
ment of prior therapy then enables you to plan 
current therapy and escalate from theophylline, 
ephedrine and adrenaline, to high dose steroid 
therapy and hopefully avoid respiratory failure 
and intubation. 
Arterial Blood Gases. The major initial defect 
in asthma is hypoxemia, as large areas of the lung 
that have excellent perfusion get progressively less 
ventilation, shunting poorly oxygenated blood into 
the arterial circulation. Initially, the asthmatic in 
respiratory distress can easily overventilate the un-
involved areas of the lung lowering arterial C02 
(Pac0 ,). The classical arterial gases of the dyspneic, 
but non-fatigued asthmatic, are a low Pa 0 , (50-
60 mm Hg) and a low Paco, (20-30 mm Hg). As 
the patient tires, is sedated, gets worse, and is re· 
strained in bed, he will begin to move less air, and 
underventilation will begin with the Paco, approach-
ing normal. This is a grave prognostic sign. 
If the arterial oxygen rises as the Pco, rises 
and the patient is more comfortable, all is well. If 
the arterial oxygen falls and the Pco, approaches 
normal, you should immediately escalate your ther-
apy (Table 6). 
TABLE 4. 
COMMON ERRORS IN MANAGEMENT 
Too Little Steroids Too Late 
Sedation 
High Flow Oxygen 
Patient Put in Bed 
Tracheostomy 
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Tired 
Old 
Fat 
TABLE 5. 
PATIENTS AT RISK 
Chronic Bronchitis and Emphysema 
Heart Disease 
Escalation of Drug Therapy. 
Combination Tablets and lsupre'tJ9. Most pa-
tients with asthma who present to the physician 
with a severe episode have already tried regular 
therapy with one of the phenobarbital, theophyl-
line, or ephedrine combinations such as Tedra!® or 
Quadrinal®. They have generally used, and at 
times have overused, an Isuprel® preparation. 
These drugs then have little place in the manage-
ment of the severe asthmatic. It is important, how-
ever, to obtain specific historical facts about their 
use in planning therapy. A patient who has had 
little or no prior medication can be expected to 
respond more rapidly to less medication. 
One investigator has found that patients with 
severe asthma are specifically unresponsive to 
Isuprel®, so that response to Isuprel® was a mea-
sure not only of the severity of the disease, but 
also an index of the patient's response to other 
therapy, primarily steroids. More and more Isu-
prel® is then used by the worsening patient with 
less and less results. At times the Isuprel '.!ll has 
been shown to have been responsible for increas-
ing the asthma and may actually cause hypoxemia. 
Epinephrine and Aminophyllin. The response 
to 0.3 cc of epinephrine subcutaneously can at 
times be magical and should always be tried. The 
effect occurs within minutes and may last an 
hour. If no results are obtained after three doses 
TABLE 6. 
BOTH STATES MAY BE AsSOCIATED WITH REDUCTION 
IN WHEEZING AND A QUIET PATIENT 
Po,-60 
Pco,- 30 
pH-7.48 
! 
P0 ,-70 
Pco,-40 
pH-7.40 
P0 ,-50 
-> Pco,- 40 WORRY! 
pH- 7.4 ACT! 
REJOICE! 
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repeated at 15 minute intervals, a response will 
usually not be obtained. The response to IV ami-
nophyllin may be equally as rapid and last for 
hours, frequently as long as six. The dose must 
be large-500 mg for an adult-and must be 
given over 15-45 minutes, not over hours in a 
large bottle of fluids. Two methods are equally 
acceptable: 
I. 500 mg ( a 20 cc ampule) given intra-
venously by syringe, over a IO minute 
period. This is excellent if you have 
the time. 
2. 500 mg in 250 cc glucose and water 
given by IV drip over a 30-60 minute 
period may be equally effective. 
Decisions. Only the consultant the next morn-
ing has the benefit of the clearly outlined flow 
sheet documenting blood gases, clinical state, and 
t!me of the therapeutic maneuvers. In actual prac-
ttc~, the patient arrives in respiratory distress, ar-
terial gases are obtained, and the above medica-
tions are given-epinephrine X2 followed by 
500 mg of IV aminophyllin. This takes approx-
imately one or one and one-half hours. The ini-
tial blood gases become known to the physician 
ab~ut hal_f way through this therapy. He usually 
waits until 15-20 minutes after the aminophyllin 
is given and repeats the arterial gases and pH. 
Initial Gases. If the Paco, is below 50 mm Hg, 
supplemental oxygen is begun (24 or 28% ventimask). 
If the Paco, is greater than 40 mm Hg and the patient 
has not obtained evident clinical improvement from 
?is initial therapy, 250 mg of hydrocortisone is given 
mtravenously in addition to the other drugs previously 
described. 
Second Arterial Gases. These results have 
usually been obtained at a time when full thera-
peutic benefits will have occurred from epine-
phrine and aminophyllin therapy. A lack of clinical 
response by the patient and a lack of significant 
reduction in Paco, dictates that aggressive steroid 
!herapy should be begun. If the Paco, has dropped 
mto the 30 mm Hg range, therapy with aminophyllin 
and epinephrine can be continued and a maintenance 
drug such as Tedra!® SA begun at an appropriate 
time. 
Steroid Therapy. 
General Considerations. There is no reason 
to give hydrocortisone except for the initial dosage. 
There is theoretical evidence that the therapeutic 
effect of hydrocortisone should be more rapid 
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than prednisolone, but there is little data. I am in 
agreement with Sheehy et al. that airway resis-
tance is reduced by steroids "in several hours" 
( 4). This has been shown to be true by the stud-
ies of Pinkerton and Van Meter (1) . 
This brings up the practical consideration that 
by the time one decides to escalate to steroid 
therapy one must wait one to two hours for thera-
peutic effect. One must then give steroids one or 
two hours before they are needed. This is why 
250 mg of hydrocortisone is given if the initial 
gases indicate even slight C02 retention instead 
of awaiting the second set two hours later. Pinker-
ton and Van Meter (1) could show little differ-
ence in the dose response curves of oral and IV 
steroids. However, in a seriously ill patient who 
may vomit, the intravenous method is preferable. 
Dosage Schedule. As long as the patient is in 
respiratory distress and the Paco, is 44 mm Hg 
or above, prednisolone 50 mg should be given every 
two hours. If the Paco, continues to rise, the dosage 
should be increased to I 00 mg every one to two 
hours. 
Pediatric Dosage. In severe asthma (as de-
fined under "Initial Gases") 7 mg/ kg of hy-
drocortisone should be given as an initial stat 
dose. Another 7 mg/ kg of hydrocortisone may 
be given during the next 24 hours in divided 
doses. As is true in adults, there is little specific 
data to direct prednisone therapy in children 
within narrow dosage guidelines. 
Mucolytic A gents. Hydration with appropriate 
intravenous fluids and aggressive therapy of as-
thma . are the only two mucolytic techniques of 
proven benefit. Glyceryl guacolate (Robitussin®) 
is of proven uselessness and acetylcysteine (Mu-
comyst®) will provoke asthma. Humidified air 
can be added to the ventimask if the patient is a 
mouth breather, but humidity and heat are usually 
no problem as long as the nose is still in the cir-
cuit. 
Intubation and Ventilation. 
Indications for Intubation. A nsmg Paco, 
above 60 mm Hg, a pH below 7 .2, increasing fa-
tigue, increasing somnolence with inability to cough 
despite the therapy as outlined above are indi-
cations for intubation and ventilation. 
General Considerations. The use of the cuffed 
nasotracheal tube has revolutionized the respira-
tory care of severe asthma. Only in unusual cir-
cumstances should tracheostomy have to be done 
HUNT: SEVERE ASTHMA 
for asthma. Once nasotracheal intubation is ac-
complished and the patient is being artificially 
ventilated, aggressive therapy must be continued. 
Unlike the patient with chronic bronchitis and 
emphysema, the patient with asthma responds 
quickly and fairly predictably to therapy (pri-
marily corticosteroids) and can be weaned from 
the ventilator in 24 to 72 hours. The unfortunate 
tendency is for the physician to relax following in-
tubation of the patient. Unless the appropriate ther-
apy is continued, weaning from the ventilator can be 
prolonged by a relapse which increases the pos-
sibility that tracheostomy will need to be done. 
Plan of Action. The physician should pre-
sume that with appropriate therapy and barring 
serious complications, the patient can be extubated 
within 48 hours. The first twelve hours that the 
patient is on the ventilator should not be compli-
cated by premature weaning procedures. The fa-
tigued patient should be allowed to rest. His abil-
ity to cycle with the ventilator should be en-
hanced with diazepam (Valium®) or if this is not 
immediately effective, with 5 to 10 mg of intra-
venous morphine (given every one to four hours 
as neeqed). Obviously the patient cannot be simul-
taneously sedated for control of ventilation and 
weaned from the ventilator, although this is fre-
quently tried with disastrous results. Prednisone 
100 mg every two hours should be continued 
during this most important phase of therapy. 
Choice of Ventilator. The tendency of a naso-
tracheal tube to leak, coupled with the extremely 
high airway pressures (3~0 cm H20) necessary to 
ventilate asthmatics, makes pressure cycled ventilators 
(Bird or Bennett) poor choices. A volume controlled 
ventilator such as the Bennett MA-I or the Emerson 
postoperative ventilator is usually necessary for 
effective ventilation of these noncompliant lungs. 
The MA-I enables the respiratory care personnel to 
easily monitor tidal volumes and oxygen percentage of 
inspired air (F10 .). Both machines will intermittently 
and automatically hyperinflate the patient's lungs to 
reduce atelectasis. Both are dependable machines. 
Complications. All of the legion of complica-
tions incident to intubation and mechanical ven-
tilation of course can occur. The excellent prog-
nosis for return to normal in these patients should 
make their recognition and reversal all the more 
important. Several complications however are more 
peculiar to the asthmatic. 
Pneumothorax. In the pediatric patient, the 
HUNT: SEVERE ASTHMA 
extremely high airway pressures needed for venti-
lation make this a common complication. Insertion 
of a chest tube with adequate seal is imperative 
to prevent a tension pneumothorax. This is a rare 
complication in adults. 
Overventilation with Alkalosis. The very na-
ture of the disease makes this complication po-
tentially common and severe. The patient with 
severe, reversible airway obstruction is connected 
to an efficient ventilator, and aggressive appropriate 
therapy is given. Success in therapy will almost 
always result in hyperventilation, unless blood 
gases are monitored frequently as the patient im-
proves and the minute ventilation reduced. 
Cardiovascular Collapse as Mechanical Ven-
tilation is Begun. This is more common in the pa-
tient with emphysema since the high airway pres-
sures are transmitted more readily to the heart 
through abnormal lung tissue hindering right heart 
filling. The asthmatic has some protection due to 
the normal lung parenchyma. However, the com-
bination of high inspiratory airway pressures, 
hypovolemia, and a short expiration time may 
rapidly reduce cardiac output even in the asthma-
tic. The physician must prolong expiration as much 
as possible relative to inspiratory time, reduce 
tidal volumes even if C02 cannot be lowered ini-
tially, and immediately correct the hypovolemic 
state. 
Weaning. Improvement can be judged by a 
return of the Paco , to normal (30-40 mm Hg) 
and a reduction in the percentage of oxygen nec-
essary to maintain Pa 0 , within a physiologic range 
(70-100 mm Hg). Reduction in airway obstruction 
can be monitored by following the "effective com-
pliance" (tidal volume divided by airway pressure 
expressed as liters/ cm H20). 
If at the end of 12 hours, blood gases and pH 
are normal and the effective compliance has 
doubled, sedation should be discontinued and the 
patient's ventilatory capabilities measured, using 
a Wright Respirometer. If it can be determined 
that the tidal volume is greater than 5 cc/ kg and 
the vital capacity greater than 10 cc/ kg, a pe-
riod of time off the ventilator should be moni-
tored with blood gas measurements ( arterial 
puncture 15-30 minutes off ventilator with pa-
tient receiving humidified 28-30% 0 2 by means 
of a Briggs T-piece). If the patient is able to 
maintain a normal or reduced Paco,, extubation 
should be considered. Alternately this procedure 
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is repeated every 12 hours or at even shorter in-
tervals depending upon the observed rate of im-
provement. 
Preparing for Discharge. The exciting part 
of the therapy is now over, <1nd the tendency to-
ward management errors increases. If the reason 
for the onset of the severe episode of asthma is 
known and has been corrected (infection, ex-
posure to irritant fumes, resolved psychic trauma) 
then the steroid dosage can be quickly reduced 
to 100-200 mg of prednisone given as a single 
daily dose, then every other day, and finally dis-
charge of the patient on 10 or 20 mg of pred-
nisone every other day. If the cause of the asthma 
remains unknown, caution will have to be exer-
cised in the rapid reduction of steroids. 
Two major facts should be borne in mind: 
1) Even large amounts of prednisone (50-100 mg) 
given as a single early morning dose may be 
taken by the patient for up to 30 days without 
significant adrenal suppression. 2) Alternate day 
prednisone therapy, again a single early morning 
dose, can be given with little danger of side ef-
fects and may be continued for months. 
Summary. The successful management of se-
vere asthma involves recognition and aggressive 
appropriate therapy, with rapid escalation to ster-
oid therapy as soon as indicated. Intubation with 
a nasotracheal tube and ventilation with a vol-
ume controlled mechanical ventilator should be an 
available option in therapy. Tracheostomy need 
rarely be done since most patients can be extu-
bated within 72 hours . 
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